The BVA-100 (Blood Volume Analyzer) is a revolutionary instrument, developed by DAXOR Corporation and cleared by the FDA, to precisely measure blood volume in the human body.

Read More

Key Features

  • Superior  blood volume measurement
  • Results in under 1 hour
  • Clinically proven — used in leading hospitals

Latest News

Daxor Receives Two Patents, One for Measurement of Total Body Albumin and a Second Patent for Improved Accuracy of Blood Volume Measurement

Daxor has received approval from the US Patent Office for a Total Body Albumin Analyzer, US Patent # 9,002,656. The patent for the total body albumin analyzer is the first one issued for an instrument to measure the total albumin within the human body.  Albumin is the major carrier molecule in the human body for […]

Read More

Daxor Announces an Update on its Stock Buyback Program and Changes in Marketing

Daxor Corporation, (NYSE MKT: DXR) an investment company with medical instrumentation and biotechnology operations announced an update on its stock buyback program today. The Board of Directors of Daxor Corporation has given management the authority to repurchase up to 250,000 shares of its common stock in 2015. From January 1, 2015 through August 12, 2015, […]

Read More

Daxor Announces the receipt of a contract for the placement of a BVA-100 Blood Volume Analyzer at Self Regional Healthcare in Greenwood, South Carolina

Daxor Corporation announced the receipt of a signed contract from Self Regional Healthcare of Greenwood, South Carolina for the placement of a BVA-100 Blood Volume Analyzer. Self Regional was founded in 1951 as Self Memorial Hospital. Self Regional Healthcare serves Greenwood and the surrounding seven counties by offering advanced care through their Cancer Center, Heart Center, […]

Read More